281 related articles for article (PubMed ID: 8496678)
1. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
Stålhammar-Carlemalm M; Stenberg L; Lindahl G
J Exp Med; 1993 Jun; 177(6):1593-603. PubMed ID: 8496678
[TBL] [Abstract][Full Text] [Related]
2. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Infect Immun; 1996 Sep; 64(9):3518-23. PubMed ID: 8751893
[TBL] [Abstract][Full Text] [Related]
3. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.
Areschoug T; Stålhammar-Carlemalm M; Larsson C; Lindahl G
Infect Immun; 1999 Dec; 67(12):6350-7. PubMed ID: 10569749
[TBL] [Abstract][Full Text] [Related]
4. A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.
Lachenauer CS; Madoff LC
Infect Immun; 1996 Oct; 64(10):4255-60. PubMed ID: 8926097
[TBL] [Abstract][Full Text] [Related]
5. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Vaccine; 1999 Feb; 17(5):454-8. PubMed ID: 10073723
[TBL] [Abstract][Full Text] [Related]
6. Identification of a family of streptococcal surface proteins with extremely repetitive structure.
Wästfelt M; Stâlhammar-Carlemalm M; Delisse AM; Cabezon T; Lindahl G
J Biol Chem; 1996 Aug; 271(31):18892-7. PubMed ID: 8702550
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
8. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
[TBL] [Abstract][Full Text] [Related]
9. Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.
Rose F; Roovers S; Fano M; Harloff-Helleberg S; Kirkensgaard JJK; Hejnaes K; Fischer P; Foged C
Mol Pharm; 2018 Jul; 15(7):2584-2593. PubMed ID: 29745668
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
Larsson C; Holmgren J; Lindahl G; Bergquist C
Infect Immun; 2004 Feb; 72(2):1184-7. PubMed ID: 14742572
[TBL] [Abstract][Full Text] [Related]
11. The Rib and alpha proteins define a family of group B streptococcal surface proteins that confer protective immunity.
Wästfelt M; Stålhammar-Carlemalm M; Delisse AM; Cabezon T; Lindahl G
Adv Exp Med Biol; 1997; 418():619-22. PubMed ID: 9331728
[No Abstract] [Full Text] [Related]
12. Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.
Gravekamp C; Horensky DS; Michel JL; Madoff LC
Infect Immun; 1996 Sep; 64(9):3576-83. PubMed ID: 8751902
[TBL] [Abstract][Full Text] [Related]
13. Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.
Larsson C; Lindroth M; Nordin P; Stålhammar-Carlemalm M; Lindahl G; Krantz I
Arch Dis Child Fetal Neonatal Ed; 2006 Nov; 91(6):F403-8. PubMed ID: 17056838
[TBL] [Abstract][Full Text] [Related]
14. Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine.
Stålhammar-Carlemalm M; Waldemarsson J; Johnsson E; Areschoug T; Lindahl G
Cell Host Microbe; 2007 Dec; 2(6):427-34. PubMed ID: 18078694
[TBL] [Abstract][Full Text] [Related]
15. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
Madoff LC; Paoletti LC; Tai JY; Kasper DL
J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
[TBL] [Abstract][Full Text] [Related]
16. Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.
Mavenyengwa RT; Maeland JA; Moyo SR
Clin Vaccine Immunol; 2009 Sep; 16(9):1302-8. PubMed ID: 19587152
[TBL] [Abstract][Full Text] [Related]
17. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.
Brodeur BR; Boyer M; Charlebois I; Hamel J; Couture F; Rioux CR; Martin D
Infect Immun; 2000 Oct; 68(10):5610-8. PubMed ID: 10992461
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with highly purified cell surface proteins confers protection against experimental group B streptococcal infection.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Adv Exp Med Biol; 1997; 418():851-3. PubMed ID: 9331786
[No Abstract] [Full Text] [Related]
19. Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins.
Persson E; Berg S; Bevanger L; Bergh K; Valsö-Lyng R; Trollfors B
Clin Microbiol Infect; 2008 Jan; 14(1):66-73. PubMed ID: 18034863
[TBL] [Abstract][Full Text] [Related]
20. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.
Michel JL; Madoff LC; Kling DE; Kasper DL; Ausubel FM
Infect Immun; 1991 Jun; 59(6):2023-8. PubMed ID: 1674738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
